Nasdaq:US$13.33 (+0.13) | HKEX:HK$20.62 (+0.16) | AIM:£2.09 (+0.11)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate